Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperlipoproteinemia Type II | 29 | 2024 | 407 | 5.430 |
Why?
|
Dyslipidemias | 15 | 2023 | 873 | 4.730 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 20 | 2023 | 539 | 3.210 |
Why?
|
Cardiovascular Diseases | 46 | 2024 | 15661 | 2.680 |
Why?
|
Hypercholesterolemia | 13 | 2024 | 1145 | 2.330 |
Why?
|
Coronary Aneurysm | 12 | 2023 | 234 | 2.190 |
Why?
|
Cholesterol, LDL | 25 | 2024 | 2403 | 2.090 |
Why?
|
Mass Screening | 19 | 2024 | 5457 | 1.940 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 15 | 2022 | 3253 | 1.730 |
Why?
|
American Heart Association | 18 | 2024 | 1051 | 1.690 |
Why?
|
Atherosclerosis | 15 | 2024 | 3431 | 1.510 |
Why?
|
Cholesterol | 16 | 2023 | 2913 | 1.490 |
Why?
|
Triglycerides | 14 | 2022 | 2464 | 1.460 |
Why?
|
Lipids | 14 | 2023 | 3345 | 1.350 |
Why?
|
Health Behavior | 6 | 2021 | 2649 | 1.310 |
Why?
|
Cardiology | 10 | 2022 | 1701 | 1.200 |
Why?
|
Anticholesteremic Agents | 10 | 2023 | 972 | 1.180 |
Why?
|
Hypertension | 15 | 2024 | 8617 | 1.110 |
Why?
|
Child | 96 | 2024 | 80960 | 1.110 |
Why?
|
Adolescent | 86 | 2024 | 89244 | 1.070 |
Why?
|
Hyperlipidemias | 7 | 2022 | 773 | 1.060 |
Why?
|
Preventive Health Services | 6 | 2021 | 570 | 0.960 |
Why?
|
Nutrition Surveys | 12 | 2024 | 1738 | 0.940 |
Why?
|
Health Status Indicators | 2 | 2021 | 971 | 0.860 |
Why?
|
Guideline Adherence | 5 | 2017 | 2241 | 0.800 |
Why?
|
Health Knowledge, Attitudes, Practice | 6 | 2024 | 4056 | 0.800 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2023 | 252 | 0.760 |
Why?
|
Pediatrics | 11 | 2022 | 3628 | 0.730 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2022 | 3447 | 0.710 |
Why?
|
Preventive Medicine | 2 | 2020 | 246 | 0.690 |
Why?
|
Heart Defects, Congenital | 6 | 2024 | 4712 | 0.690 |
Why?
|
Life Style | 9 | 2022 | 3931 | 0.680 |
Why?
|
Systemic Inflammatory Response Syndrome | 6 | 2023 | 621 | 0.680 |
Why?
|
Directive Counseling | 1 | 2021 | 171 | 0.660 |
Why?
|
Prevalence | 16 | 2024 | 15879 | 0.660 |
Why?
|
Practice Guidelines as Topic | 12 | 2020 | 7460 | 0.660 |
Why?
|
Risk Factors | 54 | 2024 | 74976 | 0.640 |
Why?
|
Humans | 176 | 2024 | 768970 | 0.610 |
Why?
|
Awareness | 2 | 2020 | 653 | 0.600 |
Why?
|
Heart Diseases | 7 | 2021 | 2819 | 0.590 |
Why?
|
United States | 52 | 2024 | 73186 | 0.580 |
Why?
|
Hyperglycemia | 2 | 2022 | 1389 | 0.570 |
Why?
|
Health Status | 5 | 2020 | 4095 | 0.560 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2018 | 241 | 0.530 |
Why?
|
Alanine Transaminase | 1 | 2019 | 606 | 0.520 |
Why?
|
Young Adult | 46 | 2024 | 60131 | 0.510 |
Why?
|
Hypertriglyceridemia | 3 | 2019 | 293 | 0.510 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 390 | 0.510 |
Why?
|
Creatine Kinase | 1 | 2017 | 684 | 0.480 |
Why?
|
Female | 94 | 2024 | 397515 | 0.470 |
Why?
|
Obesity | 20 | 2023 | 13091 | 0.460 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2013 | 325 | 0.460 |
Why?
|
Diet, Fat-Restricted | 1 | 2017 | 328 | 0.460 |
Why?
|
Male | 87 | 2024 | 365203 | 0.450 |
Why?
|
Boston | 12 | 2023 | 9377 | 0.440 |
Why?
|
Urban Health | 1 | 2016 | 535 | 0.440 |
Why?
|
Women's Health | 3 | 2021 | 2081 | 0.440 |
Why?
|
Cholesterol, HDL | 7 | 2022 | 1820 | 0.430 |
Why?
|
Patient Transfer | 1 | 2020 | 792 | 0.420 |
Why?
|
Coronary Vessels | 4 | 2020 | 3124 | 0.420 |
Why?
|
Echocardiography | 8 | 2023 | 5047 | 0.420 |
Why?
|
Child, Preschool | 30 | 2024 | 42683 | 0.420 |
Why?
|
Biosensing Techniques | 1 | 2019 | 662 | 0.420 |
Why?
|
Muscular Diseases | 1 | 2017 | 553 | 0.410 |
Why?
|
Immunoglobulins, Intravenous | 7 | 2020 | 667 | 0.400 |
Why?
|
Tobacco Smoke Pollution | 2 | 2016 | 828 | 0.400 |
Why?
|
Risk Reduction Behavior | 9 | 2020 | 1119 | 0.400 |
Why?
|
Income | 2 | 2022 | 1879 | 0.390 |
Why?
|
Attitude of Health Personnel | 4 | 2024 | 3928 | 0.380 |
Why?
|
Risk Assessment | 17 | 2023 | 24333 | 0.370 |
Why?
|
Homozygote | 6 | 2024 | 1780 | 0.370 |
Why?
|
Blood Pressure | 12 | 2023 | 8544 | 0.370 |
Why?
|
Equipment Design | 1 | 2019 | 3530 | 0.370 |
Why?
|
Blood Component Removal | 2 | 2024 | 132 | 0.370 |
Why?
|
Coronary Artery Disease | 6 | 2024 | 6569 | 0.360 |
Why?
|
C-Reactive Protein | 8 | 2020 | 3859 | 0.350 |
Why?
|
Longevity | 1 | 2018 | 1077 | 0.350 |
Why?
|
Energy Intake | 2 | 2019 | 2146 | 0.340 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2020 | 12253 | 0.340 |
Why?
|
Disease Management | 1 | 2020 | 2537 | 0.330 |
Why?
|
Thrombosis | 3 | 2020 | 2956 | 0.330 |
Why?
|
Body Mass Index | 12 | 2020 | 13055 | 0.330 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2019 | 1399 | 0.320 |
Why?
|
Pulse | 1 | 2009 | 218 | 0.310 |
Why?
|
Health Promotion | 4 | 2021 | 2210 | 0.310 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3421 | 0.310 |
Why?
|
Carotid Artery Diseases | 1 | 2015 | 878 | 0.310 |
Why?
|
Dietary Supplements | 3 | 2020 | 3443 | 0.300 |
Why?
|
Adult | 45 | 2024 | 223851 | 0.300 |
Why?
|
Research Report | 3 | 2016 | 369 | 0.300 |
Why?
|
Counseling | 4 | 2022 | 1554 | 0.290 |
Why?
|
Advisory Committees | 3 | 2017 | 797 | 0.290 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2012 | 856 | 0.280 |
Why?
|
Age Factors | 10 | 2020 | 18435 | 0.270 |
Why?
|
Infant | 18 | 2024 | 36556 | 0.270 |
Why?
|
Policy Making | 2 | 2020 | 546 | 0.270 |
Why?
|
Delayed Diagnosis | 2 | 2021 | 468 | 0.260 |
Why?
|
Retrospective Studies | 22 | 2024 | 81903 | 0.250 |
Why?
|
Adiposity | 3 | 2018 | 1895 | 0.240 |
Why?
|
Fever | 3 | 2023 | 1619 | 0.240 |
Why?
|
Follow-Up Studies | 13 | 2024 | 39394 | 0.230 |
Why?
|
Myocarditis | 2 | 2022 | 803 | 0.230 |
Why?
|
Cross-Sectional Studies | 11 | 2022 | 26395 | 0.210 |
Why?
|
Feeding Behavior | 1 | 2015 | 3205 | 0.210 |
Why?
|
Evidence-Based Medicine | 3 | 2020 | 3709 | 0.210 |
Why?
|
Immunization | 2 | 2017 | 1220 | 0.200 |
Why?
|
Endothelium, Vascular | 3 | 2019 | 4428 | 0.200 |
Why?
|
Genetic Testing | 7 | 2024 | 3591 | 0.200 |
Why?
|
Apolipoproteins B | 3 | 2019 | 386 | 0.200 |
Why?
|
Parents | 6 | 2024 | 3597 | 0.190 |
Why?
|
Adrenal Cortex Hormones | 2 | 2020 | 1892 | 0.190 |
Why?
|
Food | 2 | 2016 | 768 | 0.180 |
Why?
|
Adipocytes | 1 | 2008 | 1199 | 0.180 |
Why?
|
Health Surveys | 5 | 2016 | 4055 | 0.180 |
Why?
|
Consensus | 4 | 2024 | 3214 | 0.180 |
Why?
|
Overweight | 2 | 2017 | 2448 | 0.180 |
Why?
|
Health Policy | 1 | 2013 | 2700 | 0.170 |
Why?
|
Warfarin | 2 | 2020 | 1493 | 0.170 |
Why?
|
Pulmonary Valve | 1 | 2024 | 413 | 0.170 |
Why?
|
Prospective Studies | 12 | 2021 | 54962 | 0.170 |
Why?
|
Primary Prevention | 2 | 2021 | 1187 | 0.170 |
Why?
|
Registries | 6 | 2023 | 8384 | 0.170 |
Why?
|
Hospitals, Pediatric | 2 | 2024 | 1876 | 0.170 |
Why?
|
Attitude to Health | 2 | 2020 | 2025 | 0.160 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 299 | 0.160 |
Why?
|
Nicotine | 1 | 2024 | 680 | 0.160 |
Why?
|
Stroke | 5 | 2024 | 9756 | 0.160 |
Why?
|
Diet, Sodium-Restricted | 1 | 2020 | 291 | 0.160 |
Why?
|
Lipoproteins | 2 | 2024 | 880 | 0.160 |
Why?
|
Atrioventricular Block | 1 | 2020 | 141 | 0.150 |
Why?
|
Folic Acid Antagonists | 1 | 1998 | 74 | 0.150 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2020 | 344 | 0.150 |
Why?
|
Food Supply | 1 | 2024 | 544 | 0.150 |
Why?
|
Chemoprevention | 1 | 2020 | 326 | 0.150 |
Why?
|
Canada | 2 | 2020 | 2130 | 0.150 |
Why?
|
Treatment Outcome | 13 | 2024 | 65480 | 0.150 |
Why?
|
Brachial Artery | 2 | 2010 | 373 | 0.150 |
Why?
|
Aortic Valve Insufficiency | 1 | 2022 | 577 | 0.150 |
Why?
|
Self Report | 3 | 2018 | 3773 | 0.150 |
Why?
|
Proprotein Convertases | 2 | 2016 | 95 | 0.140 |
Why?
|
Ventricular Remodeling | 2 | 2017 | 1282 | 0.140 |
Why?
|
Blood Pressure Determination | 2 | 2018 | 646 | 0.140 |
Why?
|
Infant, Newborn | 7 | 2024 | 26428 | 0.140 |
Why?
|
Goals | 1 | 2022 | 717 | 0.140 |
Why?
|
Continuity of Patient Care | 1 | 2024 | 1076 | 0.140 |
Why?
|
Liver Function Tests | 1 | 2019 | 526 | 0.140 |
Why?
|
Intraoperative Complications | 1 | 2004 | 1176 | 0.140 |
Why?
|
Hypolipidemic Agents | 1 | 2021 | 609 | 0.140 |
Why?
|
Qualitative Research | 3 | 2024 | 3143 | 0.140 |
Why?
|
Aortic Coarctation | 1 | 2019 | 278 | 0.140 |
Why?
|
Immunomodulation | 1 | 2020 | 549 | 0.140 |
Why?
|
Comorbidity | 7 | 2018 | 10592 | 0.130 |
Why?
|
Sex Factors | 4 | 2019 | 10633 | 0.130 |
Why?
|
Insulin Resistance | 3 | 2017 | 3982 | 0.130 |
Why?
|
Health Status Disparities | 2 | 2019 | 1886 | 0.130 |
Why?
|
Educational Status | 1 | 2024 | 2515 | 0.130 |
Why?
|
Public Health | 3 | 2020 | 2680 | 0.130 |
Why?
|
Private Sector | 1 | 2019 | 396 | 0.130 |
Why?
|
Incidence | 8 | 2021 | 21547 | 0.130 |
Why?
|
India | 1 | 2022 | 2334 | 0.130 |
Why?
|
Coronary Disease | 4 | 2023 | 5919 | 0.130 |
Why?
|
Pacemaker, Artificial | 1 | 2021 | 828 | 0.130 |
Why?
|
Financing, Government | 1 | 2019 | 473 | 0.130 |
Why?
|
Developmental Disabilities | 1 | 2004 | 1520 | 0.120 |
Why?
|
Censuses | 1 | 2016 | 198 | 0.120 |
Why?
|
Middle Aged | 17 | 2024 | 223737 | 0.120 |
Why?
|
Aorta | 2 | 2022 | 2046 | 0.120 |
Why?
|
Forecasting | 1 | 2024 | 2945 | 0.120 |
Why?
|
Morbidity | 1 | 2020 | 1757 | 0.120 |
Why?
|
Lipodystrophy | 1 | 2016 | 145 | 0.120 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2016 | 294 | 0.120 |
Why?
|
Research Subjects | 1 | 2017 | 249 | 0.120 |
Why?
|
Glycerol Kinase | 1 | 2014 | 15 | 0.120 |
Why?
|
Predictive Value of Tests | 4 | 2024 | 15471 | 0.120 |
Why?
|
Heart Valve Diseases | 1 | 2022 | 1030 | 0.120 |
Why?
|
Societies, Medical | 4 | 2019 | 3968 | 0.120 |
Why?
|
Drug Utilization | 1 | 2020 | 1191 | 0.120 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 1 | 2014 | 32 | 0.120 |
Why?
|
Genetic Counseling | 1 | 2018 | 634 | 0.120 |
Why?
|
Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2014 | 14 | 0.120 |
Why?
|
Glucose | 2 | 2022 | 4352 | 0.110 |
Why?
|
Hepatomegaly | 1 | 2014 | 84 | 0.110 |
Why?
|
Drug Recalls | 1 | 2013 | 20 | 0.110 |
Why?
|
Focus Groups | 1 | 2020 | 1462 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2020 | 10400 | 0.110 |
Why?
|
Perception | 1 | 2020 | 1209 | 0.110 |
Why?
|
Utilization Review | 1 | 2015 | 384 | 0.110 |
Why?
|
Benchmarking | 2 | 2018 | 1059 | 0.110 |
Why?
|
Decision Making | 3 | 2016 | 3953 | 0.110 |
Why?
|
Nervous System Diseases | 1 | 2004 | 1665 | 0.110 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2024 | 1568 | 0.110 |
Why?
|
Neoplasms | 1 | 2022 | 22389 | 0.110 |
Why?
|
Patient Identification Systems | 1 | 2013 | 75 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2022 | 711 | 0.110 |
Why?
|
Inflammation | 3 | 2023 | 10868 | 0.110 |
Why?
|
Down-Regulation | 2 | 2020 | 2942 | 0.110 |
Why?
|
Ventricular Function, Left | 4 | 2022 | 3941 | 0.110 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12095 | 0.110 |
Why?
|
Health Planning Guidelines | 1 | 2013 | 153 | 0.110 |
Why?
|
Cities | 1 | 2015 | 543 | 0.100 |
Why?
|
Serine Endopeptidases | 2 | 2016 | 1027 | 0.100 |
Why?
|
Risk | 5 | 2019 | 9621 | 0.100 |
Why?
|
Data Interpretation, Statistical | 4 | 2018 | 2714 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.100 |
Why?
|
Drug Contamination | 1 | 2013 | 151 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.100 |
Why?
|
Nephrotic Syndrome | 1 | 2016 | 381 | 0.100 |
Why?
|
Defibrillators, Implantable | 1 | 2021 | 1498 | 0.100 |
Why?
|
Massachusetts | 3 | 2021 | 8894 | 0.100 |
Why?
|
Heptanoic Acids | 1 | 2013 | 344 | 0.100 |
Why?
|
Motivation | 1 | 2021 | 2025 | 0.100 |
Why?
|
Blood Glucose | 4 | 2017 | 6435 | 0.100 |
Why?
|
Aspirin | 2 | 2019 | 3135 | 0.090 |
Why?
|
Lipid Metabolism | 2 | 2012 | 1904 | 0.090 |
Why?
|
Fasting | 3 | 2007 | 1610 | 0.090 |
Why?
|
Aortic Valve Stenosis | 2 | 2022 | 2034 | 0.090 |
Why?
|
Cooperative Behavior | 1 | 2018 | 1515 | 0.090 |
Why?
|
Regression Analysis | 3 | 2019 | 6346 | 0.090 |
Why?
|
Circadian Rhythm | 1 | 2023 | 2593 | 0.090 |
Why?
|
Comparative Effectiveness Research | 1 | 2016 | 714 | 0.090 |
Why?
|
Primary Health Care | 3 | 2016 | 4748 | 0.090 |
Why?
|
Patient Care | 1 | 2016 | 629 | 0.090 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2011 | 119 | 0.090 |
Why?
|
Social Class | 1 | 2019 | 2009 | 0.090 |
Why?
|
Tunica Media | 1 | 2010 | 111 | 0.090 |
Why?
|
Pilot Projects | 3 | 2024 | 8748 | 0.080 |
Why?
|
Remission, Spontaneous | 1 | 2010 | 385 | 0.080 |
Why?
|
Guidelines as Topic | 2 | 2016 | 1399 | 0.080 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7861 | 0.080 |
Why?
|
Child Health Services | 2 | 2013 | 645 | 0.080 |
Why?
|
Exercise | 4 | 2023 | 5954 | 0.080 |
Why?
|
Logistic Models | 3 | 2021 | 13318 | 0.080 |
Why?
|
Population Surveillance | 1 | 2020 | 2597 | 0.080 |
Why?
|
Diabetic Angiopathies | 1 | 2014 | 806 | 0.080 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5522 | 0.080 |
Why?
|
Health Services Research | 1 | 2017 | 1818 | 0.080 |
Why?
|
Sinusitis | 1 | 1998 | 998 | 0.080 |
Why?
|
Anion Exchange Resins | 1 | 2008 | 10 | 0.080 |
Why?
|
Length of Stay | 2 | 2021 | 6526 | 0.080 |
Why?
|
Insulin | 3 | 2022 | 6610 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2004 | 3683 | 0.080 |
Why?
|
Drug Therapy | 1 | 2012 | 504 | 0.080 |
Why?
|
Anticoagulants | 3 | 2020 | 4850 | 0.080 |
Why?
|
Cause of Death | 1 | 2019 | 3721 | 0.080 |
Why?
|
Reference Values | 3 | 2017 | 4940 | 0.080 |
Why?
|
Breast Feeding | 1 | 2016 | 1364 | 0.080 |
Why?
|
Tunica Intima | 1 | 2010 | 459 | 0.070 |
Why?
|
Disease Progression | 4 | 2022 | 13674 | 0.070 |
Why?
|
Leptin | 1 | 2016 | 1597 | 0.070 |
Why?
|
Hyperemia | 1 | 2009 | 224 | 0.070 |
Why?
|
Medication Therapy Management | 2 | 2018 | 131 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1881 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2018 | 2784 | 0.070 |
Why?
|
Anthropometry | 2 | 2019 | 1345 | 0.070 |
Why?
|
Fatty Liver | 1 | 2014 | 810 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2017 | 1673 | 0.070 |
Why?
|
Pyrroles | 1 | 2013 | 1125 | 0.070 |
Why?
|
Aged | 10 | 2024 | 171786 | 0.070 |
Why?
|
Clinical Protocols | 1 | 2013 | 1445 | 0.070 |
Why?
|
Motor Activity | 2 | 2016 | 2713 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2014 | 2437 | 0.070 |
Why?
|
Patient Care Planning | 1 | 2012 | 904 | 0.070 |
Why?
|
Regional Blood Flow | 1 | 2010 | 1500 | 0.070 |
Why?
|
Cost of Illness | 3 | 2024 | 1960 | 0.070 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2008 | 394 | 0.070 |
Why?
|
Clinical Trials as Topic | 3 | 2019 | 8055 | 0.070 |
Why?
|
Cell Size | 1 | 2008 | 626 | 0.060 |
Why?
|
Postprandial Period | 1 | 2008 | 320 | 0.060 |
Why?
|
Adipokines | 1 | 2008 | 309 | 0.060 |
Why?
|
Fingers | 1 | 2009 | 512 | 0.060 |
Why?
|
Myocardium | 2 | 2022 | 4790 | 0.060 |
Why?
|
Carotid Arteries | 1 | 2010 | 943 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 3 | 2024 | 18068 | 0.060 |
Why?
|
Students | 1 | 2015 | 1744 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2012 | 1476 | 0.060 |
Why?
|
Quality Improvement | 2 | 2018 | 3860 | 0.060 |
Why?
|
Delaware | 1 | 2024 | 13 | 0.060 |
Why?
|
Pregnancy | 3 | 2023 | 30265 | 0.060 |
Why?
|
Weight Loss | 1 | 2017 | 2721 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 12562 | 0.060 |
Why?
|
Time Factors | 4 | 2021 | 40261 | 0.060 |
Why?
|
Phenotype | 5 | 2024 | 16731 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6214 | 0.060 |
Why?
|
Hyperlipoproteinemia Type I | 1 | 2024 | 11 | 0.060 |
Why?
|
Receptors, LDL | 2 | 2018 | 492 | 0.060 |
Why?
|
Pandemics | 5 | 2022 | 8749 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2020 | 5323 | 0.060 |
Why?
|
Inflammation Mediators | 2 | 2013 | 1890 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9264 | 0.050 |
Why?
|
Case-Control Studies | 5 | 2021 | 22296 | 0.050 |
Why?
|
Pennsylvania | 1 | 2024 | 615 | 0.050 |
Why?
|
Internet | 1 | 2015 | 3112 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10765 | 0.050 |
Why?
|
Waist Circumference | 2 | 2017 | 935 | 0.050 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2024 | 140 | 0.050 |
Why?
|
Steroid 12-alpha-Hydroxylase | 1 | 2022 | 9 | 0.050 |
Why?
|
Animals | 7 | 2022 | 169335 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2012 | 2339 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2008 | 1133 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36854 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10847 | 0.050 |
Why?
|
Sitosterols | 1 | 2020 | 9 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7957 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2019 | 20245 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3811 | 0.050 |
Why?
|
Immunologic Factors | 2 | 2020 | 1597 | 0.040 |
Why?
|
Phytosterols | 1 | 2020 | 55 | 0.040 |
Why?
|
Prognosis | 4 | 2024 | 30046 | 0.040 |
Why?
|
Xanthomatosis | 1 | 2020 | 32 | 0.040 |
Why?
|
Electronic Health Records | 2 | 2017 | 4879 | 0.040 |
Why?
|
New Zealand | 1 | 2020 | 360 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2004 | 682 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15951 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2014 | 12467 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 1998 | 7478 | 0.040 |
Why?
|
Terminology as Topic | 2 | 2017 | 1541 | 0.040 |
Why?
|
Bile Acids and Salts | 1 | 2022 | 399 | 0.040 |
Why?
|
Macrophage Activation Syndrome | 1 | 2020 | 124 | 0.040 |
Why?
|
Simvastatin | 1 | 2022 | 346 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 622 | 0.040 |
Why?
|
Neonatal Screening | 1 | 2024 | 619 | 0.040 |
Why?
|
Cardiac Imaging Techniques | 1 | 2021 | 280 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2024 | 490 | 0.040 |
Why?
|
Cohort Studies | 5 | 2024 | 41808 | 0.040 |
Why?
|
Biomedical Research | 1 | 2014 | 3463 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
Pain Measurement | 1 | 2009 | 3586 | 0.040 |
Why?
|
Liver | 3 | 2022 | 7578 | 0.040 |
Why?
|
Job Satisfaction | 1 | 2022 | 548 | 0.040 |
Why?
|
Troponin | 1 | 2021 | 535 | 0.040 |
Why?
|
Receptor, Insulin | 1 | 2022 | 838 | 0.040 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2017 | 1092 | 0.040 |
Why?
|
Physicians, Primary Care | 1 | 2024 | 625 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2002 | 1056 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2023 | 925 | 0.040 |
Why?
|
Legislation, Drug | 1 | 2019 | 216 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2010 | 3628 | 0.040 |
Why?
|
Coronary Vessel Anomalies | 1 | 2020 | 308 | 0.040 |
Why?
|
Amoxicillin | 1 | 1998 | 182 | 0.040 |
Why?
|
Organizational Policy | 1 | 2019 | 435 | 0.040 |
Why?
|
Mississippi | 1 | 2017 | 94 | 0.030 |
Why?
|
Gadolinium | 1 | 2022 | 965 | 0.030 |
Why?
|
Australia | 1 | 2020 | 1265 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2008 | 2905 | 0.030 |
Why?
|
Food Safety | 1 | 2016 | 23 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2008 | 3139 | 0.030 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 1 | 2016 | 62 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2023 | 1758 | 0.030 |
Why?
|
Hemorrhage | 2 | 2020 | 3466 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2020 | 603 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2007 | 6856 | 0.030 |
Why?
|
Quality Control | 1 | 1998 | 836 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2108 | 0.030 |
Why?
|
Genotype | 2 | 2023 | 13048 | 0.030 |
Why?
|
Steroids | 1 | 2020 | 938 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2017 | 382 | 0.030 |
Why?
|
Penicillins | 1 | 1998 | 406 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2020 | 1183 | 0.030 |
Why?
|
Mice, Obese | 1 | 2016 | 418 | 0.030 |
Why?
|
California | 1 | 2019 | 1443 | 0.030 |
Why?
|
Smoking Cessation | 2 | 2017 | 2085 | 0.030 |
Why?
|
Mitochondria | 1 | 2008 | 3682 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2019 | 59739 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 14201 | 0.030 |
Why?
|
Stroke Volume | 2 | 2021 | 5622 | 0.030 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2014 | 82 | 0.030 |
Why?
|
Diet | 2 | 2024 | 8088 | 0.030 |
Why?
|
Drug Resistance | 1 | 2019 | 1599 | 0.030 |
Why?
|
Social Change | 1 | 2013 | 152 | 0.030 |
Why?
|
Smoking | 2 | 2017 | 9094 | 0.030 |
Why?
|
Heart Failure | 1 | 2017 | 11879 | 0.030 |
Why?
|
Drug Approval | 1 | 2019 | 821 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2008 | 10486 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2204 | 0.020 |
Why?
|
School Health Services | 1 | 2015 | 388 | 0.020 |
Why?
|
Podocytes | 1 | 2016 | 403 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2017 | 1246 | 0.020 |
Why?
|
Chronic Disease | 2 | 2017 | 9384 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3782 | 0.020 |
Why?
|
Liver Transplantation | 1 | 2024 | 2403 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1751 | 0.020 |
Why?
|
History, 20th Century | 1 | 2019 | 2771 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 1996 | 1364 | 0.020 |
Why?
|
Research Personnel | 1 | 2016 | 590 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2268 | 0.020 |
Why?
|
Self Care | 1 | 2016 | 801 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14794 | 0.020 |
Why?
|
Physical Fitness | 1 | 2015 | 744 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2019 | 1672 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3232 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6320 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3914 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2019 | 2167 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 2019 | 1381 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2121 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2016 | 1437 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5891 | 0.020 |
Why?
|
Contrast Media | 1 | 2022 | 5334 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2018 | 2027 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4592 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3813 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7453 | 0.020 |
Why?
|
Heart | 1 | 2021 | 4447 | 0.020 |
Why?
|
Electroencephalography | 1 | 2004 | 6317 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5033 | 0.020 |
Why?
|
Vaccines | 1 | 2017 | 843 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6413 | 0.020 |
Why?
|
Diabetes Mellitus | 2 | 2017 | 5892 | 0.020 |
Why?
|
Transposition of Great Vessels | 1 | 2012 | 580 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4356 | 0.020 |
Why?
|
Acute Disease | 1 | 1998 | 7245 | 0.020 |
Why?
|
Data Collection | 1 | 2016 | 3324 | 0.020 |
Why?
|
Heterozygote | 1 | 2014 | 2798 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4628 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2016 | 6512 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2017 | 2649 | 0.020 |
Why?
|
Gene Deletion | 1 | 2014 | 2674 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6547 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3235 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 2055 | 0.020 |
Why?
|
Child Development | 1 | 2016 | 2336 | 0.010 |
Why?
|
Vaccination | 1 | 2017 | 3438 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2016 | 3840 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7603 | 0.010 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2012 | 1335 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4785 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13510 | 0.010 |
Why?
|
Mice | 2 | 2022 | 82072 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14752 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14484 | 0.010 |
Why?
|
Autoanalysis | 1 | 2000 | 70 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 6002 | 0.010 |
Why?
|
Surface-Active Agents | 1 | 2000 | 152 | 0.010 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2000 | 239 | 0.010 |
Why?
|
Mutation | 2 | 2014 | 30266 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22379 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 12801 | 0.010 |
Why?
|
Eating | 1 | 2000 | 1542 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2016 | 20776 | 0.010 |
Why?
|
Brain | 1 | 2016 | 27453 | 0.010 |
Why?
|
Models, Statistical | 1 | 1996 | 5110 | 0.000 |
Why?
|